US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $696,665,953.98 |
| Submission deadline | Deadline not published |
| Published | May 18, 2020 |
| Buyer | Office of Assistant Secretary for Preparedness and Response |
| Country | United States · VA |
| CPV code | NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING) · PSC AN17 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $696,665,953.98
- Submission deadline
- Deadline not published
- Published
- May 18, 2020
- Country
- United States
- CPV code
- NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING) · PSC AN17
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| PHLOW CORP. | US-UEI: ZZN7NVV7JKG9 | United States | $696,665,953.98 | May 18, 2020 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.
Awarding Agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response.
NAICS 325412: PHARMACEUTICAL PREPARATION MANUFACTURING.
PSC AN17: R&D- MEDICAL: BIOMEDICAL (COMMERCIALIZED).
Period of Performance: 2020-05-18 to 2027-01-13.